Traduction de «cost-effectiveness of different mrsa screening » (Néerlandais → Français) :

hospital: what have we learned?J Hosp Infect 2001; 47(1):9-18 44 Kunori T, Cookson B, Roberts JA et al. Cost-effectiveness of different MRSA screening methods.
hospital: what have we learned?J Hosp Infect 2001; 47(1):9-18 43 Kunori T, Cookson B, Roberts JA et al. Cost-effectiveness of different MRSA screening methods.

In hospitals where extensive MRSA transmission occurs over long periods of time in many care units, screening and treating healthcare worker carriers is less effective compared to the considerable financial burden and workload.
Dans les hôpitaux où se produit une transmission importante de MRSA pendant de longues périodes dans beaucoup d'unités de soin, le dépistage et le traitement des membres du personnel soignant porteurs sont moins efficaces, compte tenu de la charge de travail et des charges financières considérables.

53. Zappa M, Visioli CB, Ciatto S. Mammography screening in elderly women: efficacy and cost-effectiveness.
52. Zappa M, Visioli CB, Ciatto S. Mammography screening in elderly women: efficacy and cost-effectiveness.

56. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
55. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.

The Resident Assessment Instrument (RAI) 444 is originally developed to Only for breast cancer and colon cancer, the US has higher survival rates assess the care needs of the elderly in institutions, and has later been than Belgium (data shown in documentation sheet in Supplement S1). To extended with instruments for different care settings and subgroups. In be able to distinguish the effect of early screening from the actual care, Belgium a national pilot project (the BelRAI) is ongoing, but is not yet implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).
Belgium a national pilot project (the BelRAI) is ongoing, but is not yet be able to distinguish the effect of early screening from the actual care, implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).